In a xenoimmunized mouse model of autoimmune hepatitis, treatment with anti-CD20 at the peak of disease showed clear positive effects on the manifestation and progression of hepatitis, as represented by reductions in the mHAI and ALT [21]. The gene discussed is GPT; the disease is hepatitis A virus infection.